Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Genetron Health

Request full access

Specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment

Dongcheng District, ChinaFounded 2013Biotech & Life Sciences

About Genetron Health

Genetron Health is a precision oncology company focused on providing a full-cycle of cancer care solutions, primarily within the Chinese market. The company was co-founded in 2013 by Sizhen Wang, who serves as CEO, and Dr. Hai Yan, the Chief Scientific Officer. Wang is a serial entrepreneur with a background in financial services at Capital One and a previous venture, iTalkBB. Dr. Yan is a distinguished researcher in neuro-oncology, renowned for his work at Duke University and for identifying key genetic mutations in gliomas, which has significantly influenced tumor diagnosis and treatment.

The company's business model is structured around three main segments: diagnostics and monitoring, early screening, and biopharmaceutical development services. Revenue is primarily generated through two main channels: laboratory-developed testing (LDT) services provided via its central and joint hospital labs, and the sale of in-vitro diagnostic (IVD) products, such as medical devices and kits. The diagnostics and monitoring division represents the largest portion of revenue. Genetron Health serves a diverse client base including hospitals, physicians, pharmaceutical companies, and research institutions. It has established partnerships with over 500 hospitals and dozens of pharmaceutical firms. The company has also collaborated with global entities like AstraZeneca, Roche, and Siemens Healthineers to advance precision oncology.

Genetron Health's portfolio covers early screening, diagnosis, treatment recommendations, and continuous monitoring. A key technological innovation is the "Mutation Capsule," a platform for early cancer screening, which received FDA Breakthrough Device designation for its blood-based NGS test for early detection of hepatocellular carcinoma. Its products utilize next-generation sequencing (NGS) technology to analyze patient DNA for customized treatment plans. For biopharma partners, the company offers a suite of services including biomarker evaluation, clinical trial testing, and companion diagnostics development, leveraging its CAP and CLIA-certified laboratories. The company went public on the Nasdaq in June 2020, raising approximately $260 million in one of the largest IPOs for a Chinese healthcare company at the time. However, after facing market challenges, the company accepted a privatization offer led by CEO Sizhen Wang and was delisted from Nasdaq in March 2024.

Source: Dealroom company data

At a glance

Status
Operational
Employees
94
Open positions
1
Dealroom signal
71.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Oncology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B
Investment activity
4 companies, latest Oct 2023
Capital deployed
$12M
Preferred round
SERIES A

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
IPOOther financing Jun 2020 $0 — Undisclosed —
SERIES DOther financing Nov 2019 $71M $284M Alexandria Venture Investments · Vivo Capital · Highlight Capital —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Genetron Health website traffic

Latest recorded traffic for Genetron Health is 310 monthly website visits, down 67% over the last three months. Genetron Health's team grew 3.3% over the past year.

Latest monthly visits310 3-month web change-67% 1-year team growth+3.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Genetron Health in the Dongcheng District ecosystem

Live from Dealroom

The Genetron Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Share Capital
  • Origene Technologies
  • Zhongyuan Union Cell & Gene Eng
  • New Horizon Capital

Series B and later3 investors entered at this stage

Other known investors2 additional known investors

  • Duke University
  • Technology Pioneers | World Economic Forum
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇨🇳 China84.3%
🇮🇩 Indonesia7.8%
🇺🇸 United States5.9%
🇬🇧 United Kingdom2%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Genetron Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Genetron Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.